Skip to main content
Log in

In vivo 13C-NMR evaluation of glycogen content in a patient with glycogen storage disease

  • Published:
Journal of Inherited Metabolic Disease

Summary

Glycogen storage disease was suspected in a 10-month-old boy. Initial technical problems did not permit the determination of the precise enzyme deficiency, and type VI glycogen storage disease was only diagnosed at the age of 2 years. In the mean time, natural abundance13C nuclear magnetic resonance evaluation of muscular and hepatic glycogen content indicated normal muscular glycogen and increased hepatic glycogen in our patient, a finding which strongly argued for the diagnosis of type VI glycogen storage disease. Even though the use of nuclear magnetic resonance might seem, in this situation, a somewhat circuitous means of reaching the diagnosis, it appears that nuclear magnetic resonance could provide a useful tool for a non-invasive diagnosis of glycogen storage diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Arnold DL, Taylor DJ, Radda GK (1985) Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy.Ann Neurol 18: 189–196.

    Google Scholar 

  • Avison MJ, Rothman DL, Nadel E, Shulman RG (1988) Detection of human muscle glycogen by natural abundance13C NMR.Proc Natl Acad Sci USA 85: 1634–1636.

    Google Scholar 

  • Duboc D, Jehenson P, Tran Dinh S, Marsac C, Syrota A, Fardeau M (1987) Phosphorus NMR spectroscopy study of muscular enzyme deficiencies involving glycogenolysis and glycolysis.Neurology 37: 663–671.

    Google Scholar 

  • Harris RC, Hultman E, Nordesjo LO (1974) Glycogen, glycolytic intermediates and high-energy phosphates determined in biopsy samples of musculus quadriceps femoris of man at rest. Methods and variance of values.Scand J Clin Lab Invest 33: 109–120.

    Google Scholar 

  • Jehenson P, Duboc D, Bloch G, Fardeau M, Syrota A (1991) Diagnosis of muscular glycogenosis by in vivo natural abundance13C NMR spectroscopy.Neuromuscular Disorders 1: 99–101.

    Google Scholar 

  • Maire I, Baussan C, Moatti N, Mathieu M, Lemonnier A (1991) Biochemical diagnosis of hepatic glycogen storage diseases: 20 years French experience.Clin Biochem 24: 169–178.

    Google Scholar 

  • Moses SW (1990) Pathophysiology and dietary treatment of the glycogen storage diseases.J Pediatr Gastroenterol Nutr 11: 155–174.

    Google Scholar 

  • Ross BD, Radda GK, Gadian DG, Rocker G, Esiri M, Falconner-Smith J (1981) Examination of a case of suspected McArdle's syndrome by31P nuclear magnetic resonance.N Engl J Med 304: 1338–1342.

    Google Scholar 

  • Shin YS (1990) Diagnosis of glycogen storage disease.J Inher Metab Dis 13: 419–434.

    Google Scholar 

  • Sullivan MJ, Green HJ, Cobb FR (1990) Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure.Circulation 81: 518–527.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Labrune, P., Jehenson, P., Syrota, A. et al. In vivo 13C-NMR evaluation of glycogen content in a patient with glycogen storage disease. J Inherit Metab Dis 15, 723–726 (1992). https://doi.org/10.1007/BF01800013

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01800013

Keywords

Navigation